×

An Improved Treatment Model for Neonatal Opioid Withdrawal

The increased use of unprescribed and prescribed opioids in the accelerating opioid crisis has not spared pregnant women, and infants exposed to opioids in utero are often the unintended target of substance use disorder. Over the past decade, researchers have seen a five-fold increase in the rate of neonatal opioid withdrawal syndrome (NOWS), previously known as neonatal abstinence syndrome (NAS), in which the baby experiences uncomfortable withdrawal symptoms two to three days after birth.